[
    [
        {
            "time": "",
            "orginal_text": "拆财报丨迈瑞医疗的阿喀琉斯之踵：净利润增速持续下滑，成本持续攀升 盈利能力下降",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "净利润增速下滑",
                    "成本攀升",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "拆财报丨迈瑞医疗的阿喀琉斯之踵：净利润增速持续下滑，成本持续攀升 盈利能力下降",
            "scores": {
                "News_content": "拆财报丨迈瑞医疗的阿喀琉斯之踵：净利润增速持续下滑，成本持续攀升 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "一季度A股下挫300点 哪些基金仍然大赚？",
            "features": {
                "keywords": [
                    "A股下挫",
                    "基金",
                    "大赚"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "一季度A股下挫300点 哪些基金仍然大赚？",
            "scores": {
                "News_content": "一季度A股下挫300点 哪些基金仍然大赚？",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "83股今日获机构买入评级",
            "features": {
                "keywords": [
                    "机构买入评级",
                    "83股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "83股今日获机构买入评级",
            "scores": {
                "News_content": "83股今日获机构买入评级",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "医疗物资出口严管！7家上市公司产品获海外认证，这些公司的业绩会实现高增长吗？",
            "features": {
                "keywords": [
                    "医疗物资出口",
                    "海外认证",
                    "业绩高增长",
                    "7家上市公司"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医疗物资出口严管！7家上市公司产品获海外认证，这些公司的业绩会实现高增长吗？",
            "scores": {
                "News_content": "医疗物资出口严管！7家上市公司产品获海外认证，这些公司的业绩会实现高增长吗？",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "【国信医药】乐普医疗：业绩稳健增长，创新器械可期丨2019年报点评",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "业绩稳健增长",
                    "创新器械",
                    "2019年报"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【国信医药】乐普医疗：业绩稳健增长，创新器械可期丨2019年报点评",
            "scores": {
                "News_content": "【国信医药】乐普医疗：业绩稳健增长，创新器械可期丨2019年报点评",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "【光大医药 | 年报点评】乐普医疗：疫情短期延后刚需，心血管药械新产品群将迎来收获",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "疫情短期延后",
                    "刚需",
                    "心血管药械",
                    "新产品群",
                    "收获"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【光大医药 | 年报点评】乐普医疗：疫情短期延后刚需，心血管药械新产品群将迎来收获",
            "scores": {
                "News_content": "【光大医药 | 年报点评】乐普医疗：疫情短期延后刚需，心血管药械新产品群将迎来收获",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]